Guardant Health Lung Cancer Study

Listing Websites about Guardant Health Lung Cancer Study

Filter Type:

SHIELD LUNG Study - GuardantHealth

(1 days ago) WebAt Guardant Health, we believe a simple blood test can improve lung cancer screening compliance by overcoming barriers associated with current methods, such as low-dose CT scans, while still being effective and more accessible. To accomplish these objectives, …

https://guardanthealth.com/clinical-studies/shield/

Category:  Cancer Show Health

Clinical Studies - GuardantHealth

(4 days ago) WebThe ECLIPSE study is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of colorectal cancer compared to a …

https://guardanthealth.com/clinical-studies/

Category:  Cancer Show Health

Clinical lung cancer – Guardant Health

(7 days ago) WebThis prospective study demonstrated the clinical utility of using ctDNA to guide treatment selection in advanced cancer patients. A quarter of the patients in the NSCLC cohort were matched to targeted …

https://guardanthealth.eu/clinical-lung-cancer/

Category:  Cancer Show Health

Home - GuardantHealth

(7 days ago) WebOver 500,000 of our blood tests have been performed by 12,000 doctors to date. Our commercially available tests help inform treatment decisions for patients with advanced cancer, monitor treatment response, detect …

https://guardanthealth.com/

Category:  Cancer Show Health

Guardant Health, Inc. - NILE Study Results Demonstrating …

(1 days ago) WebGuardant Health, Inc. (Nasdaq: GH), announced that the positive results from the NILE study, a head-to-head comparison of the Guardant360® assay to …

https://investors.guardanthealth.com/press-releases/press-releases/2019/NILE-Study-Results-Demonstrating-Guardant360s-High-Concordance-to-Tissue-Testing-in-Advanced-NSCLC-Published-in-Clinical-Cancer-Research/default.aspx

Category:  Health Show Health

Guardant Health's Liquid Biopsy Wins in Head-to-Head Trial in …

(2 days ago) WebGuardant Health announced positive results from its NILE study, a head-to-head trial of its Guardant360 compared to standard-of-care tissue testing in first-line …

https://www.biospace.com/article/guardant-s-liquid-biopsy-trial-hits-primary-endpoint-for-lung-cancer/

Category:  Health Show Health

Lung Cancer: Findings from NILE Study - Guardant …

(4 days ago) WebGuideline-recommended biomarker testing was completed for 95% of patients with Guardant360® vs 32% with standard-of-care tissue testing at the time of the study. Turnaround time was 6 days faster with …

https://www.guardanthealthamea.com/guardant360/lung-cancer-findings-from-nile-study/

Category:  Health Show Health

Lung Cancer Research Findings - Guardant Health AMEA

(9 days ago) WebClinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer 1. “These results, combined with …

https://www.guardanthealthamea.com/guardant360/lung-cancer-research-findings-penn2-study/

Category:  Cancer Show Health

Clinical cancer research – Guardant Health

(1 days ago) WebNILE Study: Large prospective head-to-head trial finds Guardant360 is as effective as tissue testing in detecting NSCLC biomarkers Cell-Free DNA Analysis to Identify Genomic …

https://guardanthealth.eu/clinical-cancer-research/

Category:  Health Show Health

Guardant Health, Inc. - Head-to-Head Study Shows Guardant360 …

(8 days ago) WebData Shows First-Line Testing with Guardant Health Liquid Biopsy Uncovers 23.6 Percent More Actionable Mutations Than with Tissue Biopsy Guardant Health, Inc . …

https://investors.guardanthealth.com/press-releases/press-releases/2021/Head-to-Head-Study-Shows-Guardant360-Liquid-Biopsy-Outperforms-Tissue-Biopsy-for-Comprehensive-Genomic-Profiling-in-Advanced-Non-Small-Cell-Lung-Cancer-with-Similar-Outcomes/default.aspx

Category:  Health Show Health

Guardant Health Enrolls First Patient in SHIELD LUNG Study to …

(9 days ago) WebGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today the enrollment of the first patient in the SHIELD (Screening for HIgh …

https://zt-gateway.guardanthealth.com/2022/01/18/guardant-health-enrolls-first-patient-in-shield-lung-study-to-evaluate-accuracy-of-its-blood-test-to-detect-lung-cancer-in-high-risk-adults/

Category:  Health Show Health

Tests for Patients with Early and Advanced Stage Cancer

(2 days ago) WebGuardant360(™) TissueNext Assay Specifications. Guardant Health Inc. Redwood City, CA. Data on file. Guardant Health, Inc. Redwood City, CA. Raja R, Kuziora M, Philip Z. …

https://guardanthealth.com/products/tests-for-patients-with-early-and-advanced-stage-cancer/

Category:  Health Show Health

Guardant Health Presents New Data Showing Blood Test

(8 days ago) WebIn January 2022, Guardant Health initiated the SHIELD Lung study, a prospective, observational, multi-center basket study designed to enroll individuals …

https://www.businesswire.com/news/home/20220411005737/en/Guardant-Health-Presents-New-Data-Showing-Blood-Test-Highly-Accurate-in-Detecting-Multiple-Cancers-at-the-American-Association-for-Cancer-Research-Annual-Meeting

Category:  Health Show Health

Tests for Patients with Early-stage Cancer - GuardantHealth

(9 days ago) WebExplore Guardant Health's specifically-designed offering for patients with early-stage cancer. Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly …

https://guardanthealth.com/products/tests-for-patients-with-early-stage-cancer/

Category:  Cancer Show Health

FDA Advisory Panel Review of Guardant Health’s Shield™ Blood …

(Just Now) WebPALO ALTO, Calif., April 22, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical …

https://finance.yahoo.com/news/fda-advisory-panel-review-guardant-125200837.html

Category:  Health Show Health

Oral targeted therapy for the treatment of non–small cell lung

(9 days ago) WebLung cancer is the leading cause of cancer-related death in Canada, with non–small cell lung carcinoma (NSCLC) making up 85% of cases.1 Lung cancer has …

https://www.cmaj.ca/content/196/16/E558

Category:  Cancer Show Health

FDA to review Guardant Health's cancer screening test

(4 days ago) WebPALO ALTO, Calif. - Guardant Health , Inc. (NASDAQ:GH), a precision oncology company, has announced that its premarket approval (PMA) application for the …

https://www.investing.com/news/company-news/fda-to-review-guardant-healths-cancer-screening-test-3388823

Category:  Health Show Health

Bay Area doctors using Ion robot to detect lung cancer safer, …

(6 days ago) WebToday, a simple blood test developed by Guardant Health in Silicon Valley can detect colon cancer. "If you put a needle from the outside into the lung, the lung …

https://abc7news.com/bay-area-doctors-use-ion-robot-by-sunnyvale-based-intuitive-surgical-to-detect-lung-cancer-safer-faster-than-before/14697281/

Category:  Cancer Show Health

A blood test to detect cancer? Some patients are using them …

(2 days ago) WebA study of the Delfi lung cancer test reported more than 90 percent accuracy, and a study of Guardant Health's Shield showed an 83 percent accuracy in …

https://jewishworldreview.com/0424/cancer_blood.php3

Category:  Cancer Show Health

Guardant Health Enrolls First Patient in SHIELD LUNG Study to …

(6 days ago) Web“The SHIELD LUNG study is the second large-scale screening study initiated by Guardant Health in just over two years to evaluate the performance of our …

https://www.businesswire.com/news/home/20220118005375/en/Guardant-Health-Enrolls-First-Patient-in-SHIELD-LUNG-Study-to-Evaluate-Accuracy-of-Its-Blood-Test-to-Detect-Lung-Cancer-in-High-Risk-Adults

Category:  Health Show Health

Key Takeaways From Guardant Health Analyst Ratings

(9 days ago) WebStay up to date on Guardant Health analyst ratings. Get to Know Guardant Health Better. California, is a leader in liquid-based cancer tests for clinical and …

https://markets.businessinsider.com/news/stocks/key-takeaways-from-guardant-health-analyst-ratings-1033283747

Category:  Cancer Show Health

Early cancer-detection test maker Freenome to cut 20% of jobs

(9 days ago) WebThe study, which enrolled nearly 49,000 asymptomatic after launching in 2020 for average-risk participants ages 45-85, showed Freenome's test had a 79.2% …

https://www.bizjournals.com/sanfrancisco/news/2024/04/24/early-cancer-detection-colorectal-lung-freenome.html

Category:  Health Show Health

46 Automated Derivation of Diagnostic Criteria for Lung Cancer …

(6 days ago) Web@article{Houston202446AD, title={46 Automated Derivation of Diagnostic Criteria for Lung Cancer using Natural Language Processing on Electronic Health …

https://www.semanticscholar.org/paper/46-Automated-Derivation-of-Diagnostic-Criteria-for-Houston-Williams/03b20887ca02a6d7163c739f6df0e42683caacea

Category:  Cancer Show Health

Impact of COVID-19 pandemic among patients with lung and …

(1 days ago) WebStudy protocol. This was a retrospective cohort study at Santa Casa de Misericórdia de Belo Horizonte, a tertiary cancer center in Belo Horizonte, Southeastern …

https://bmccancer.biomedcentral.com/articles/10.1186/s12885-024-12255-0

Category:  Cancer Show Health

SHIELD LUNG Study - GuardantHealth

(1 days ago) WebShield for Cancer Screening; Guardant Reveal for Early-stage Cancer; Guardant 360 Portfolio for Advanced Cancer; Biopharma Solutions; Clinical Studies. Clinical Studies; …

https://wpad.corp.guardanthealth.com/clinical-studies/shield/

Category:  Cancer Show Health

Diagnostics Free Full-Text Advancing Evidence Generation for

(9 days ago) WebCirculating tumor DNA (ctDNA) holds promise as a biomarker for predicting clinical responses to therapy in solid tumors, and multiple ctDNA assays are in …

https://www.mdpi.com/2075-4418/14/9/912

Category:  Health Show Health

Breast cancer rates rising among Canadian women in their

(2 days ago) WebLed by Dr. Jean Seely, this study published in the Canadian Association of Radiologists Journal reviewed breast cancer cases over 35 years to shed light on trends …

https://www.sciencedaily.com/releases/2024/04/240426165227.htm

Category:  Cancer Show Health

Study reveals new liquid biopsy test could benefit thousands of …

(5 days ago) WebRead the latest news, announcements, and stories from Guardant Health. Press Releases; News and Perspectives; Media Resources; Our Company. Careers; …

https://portal-beta.guardanthealth.com/2024/04/04/study-reveals-new-liquid-biopsy-test-could-benefit-thousands-of-lung-cancer-patients/

Category:  Health Show Health

Poorer English Breast Cancer Survivors Face Higher Second

(7 days ago) WebYoung woman in bed suffering from cancer. Breast cancer survivors are more likely to develop a second form of cancer if they live in the poorest parts of …

https://www.forbes.com/sites/katherinehignett/2024/04/28/poorer-english-breast-cancer-survivors-face-higher-second-cancer-risk/

Category:  Cancer Show Health

Filter Type: